
AdAlta Investor Relations Material
Latest events

Study Update
AdAlta
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AdAlta Limited
Access all reports
AdAlta Limited is an Australian biotechnology company focused on the discovery and development of novel protein-based therapeutics. The company utilizes its proprietary i-body technology platform to create next-generation biologic drugs targeting a range of diseases, including fibrosis and immune-related conditions. AdAlta Limited is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for AdAlta Limited


Investor Presentation
AdAlta Limited


Investor Update
AdAlta Limited
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
1AD
Country
🇦🇺 Australia